# FDA 483 - Intas Pharmaceuticals Limited - July 31, 2017

Source: https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/4f76e2d8-eaeb-4ac2-a891-807bdf0b6f08

> FDA 483 for Intas Pharmaceuticals Limited on July 31, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2017-07-31
- Product Type: drugs
- Office Name: FDA District Office — Silver Springs, Maryland
- Summary: An FDA inspection of Intas Pharmaceuticals Limited in Ahmedabad, Gujarat, India, revealed a deficiency in sampling procedures for raw materials. Specifically, the firm's method for collecting composite samples from raw material containers was found to be inadequate. This indicates a potential issue with quality control and adherence to established sampling protocols.

## Related Documents

- [483 - 2022-12-02](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/aaef987c-6382-4641-8d0e-9fc48ace87ba)
- [WARNING_LETTER - 2025-09-17](https://www.globalkeysolutions.net/records/warning_letter/intas-pharmaceuticals-limited/5823afb5-cd04-4920-9a5a-ce851b44651c)
- [483 - 2019-08-02](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/d8b8b922-c242-4064-89d5-38ff992edec5)
- [483 - 2023-05-12](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/439bcecd-27da-49d0-b32b-ce7d8d990792)
- [483 - 2018-12-14](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/d7d4f9f0-3246-4bd4-b45d-b1149c0a717e)

## Related Officers

- [Steven P Donald](https://www.globalkeysolutions.net/people/steven-p-donald/431cb518-7687-408b-82e4-e525a135a26b)

Company: https://www.globalkeysolutions.net/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

Office: https://www.globalkeysolutions.net/offices/fda-district-office-silver-springs-maryland/079bb75c-3759-4baa-baed-4159edd64552